Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter-defibrillator

Europace. 2023 Oct 5;25(10):euad301. doi: 10.1093/europace/euad301.

Authors

Ian Crozier¹, Haris Haqqani², Emily Kotschet³, Christopher Wiggenhorn⁴, Jeff Lande⁴, Amy Thompson⁴, Alan Cheng⁴, Varun Bhatia⁴, David O'Donnell⁵

Affiliations

¹ Department of Cardiology, Christchurch Hospital, 2 Riccarton Avenue, PO Bag 4710, Christchurch 8140, New Zealand.
² Department of Cardiology, The Prince Charles Hospital, Brisbane, Australia.
³ Department of Caridac Rhythm Services, Monash Medical Centre, Melbourne, Australia.
⁴ Department of Cardiac Rhythm Managment, Medtronic Inc., Mounds View, MN, USA.
⁵ Department of Cardiology, The Austin Hospital, Melbourne, Australia.

Abstract

Graphical Abstract

Anteroposterior (left) and lateral (right) fluoroscopic images of fully implanted EV ICD system in situ. Image modified from Crozier et al.

MeSH terms

Defibrillators, Implantable*
Follow-Up Studies
Humans
Pilot Projects

Grants and funding

Medtronic Inc